- About Us
- Nano-Social Network
- Nano Consulting
- My Account
NaturalNano, Inc (OTCBB:NNAND) today announced that a free online video showing the step-by-step method to isolate circulating tumor cells from blood using microtubes lined with halloysite nanotubes(HNT) is available at www.jove.com/video/4248/.
Dr. Michael King, Associate Professor of Biomedical Engineering at Cornell University, has produced a video demonstrating how he used HNT lined microtubes to enhance the isolation of live circulating tumor cells (CTCs) from patient blood samples. The nanotubes, when added to the surface of polymer tubing and then coated with adhesion proteins, is a straightforward and effective way for biomedical labs to capture CTCs from blood. The cells can then be placed in culture or characterized through standard assays.
Dr. King states "The ability to create stable coatings of halloysite using an extremely thin layer of poly-L-lysine gives us a way to create nanostructured surfaces that living cells respond to. This breakthrough could impact a number of projects we have been working on for basic research and diagnostic detection of circulating tumor cells in blood."
James Wemett, NaturalNano CEO, said "We believe that the video will be very useful in educating our customers, researchers, investors, the media and other interested parties as to the long-term potential of the HNT business. In addition, NaturalNano has established on our website a portal to purchase samples of Halloysite for use in research."
About NaturalNano, Inc
NaturalNano, Inc. (OTCBB:NNAND) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by
For more information, please click here
Copyright © NaturalNano, IncIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Manchester scientists tie the tightest knot ever achieved January 13th, 2017